In 2007, Yao et al29 reported a studyin which they examined the potential therapeutic effects of a consistent, subdepressivedose of infused kallikrein and kinin on ventricular remodeling and neovascularization inrats after MI. Here, KLK4 is linked to myocardial infarction.